Skip to main content
. 2022 Oct 6;23:855. doi: 10.1186/s13063-022-06703-0

Fig. 1.

Fig. 1

Design of the Study in Parkinson Disease of Exercise (SPARX3) Trial. The moderate-intensity exercise group is assigned to exercise 4 days a week at 60–65% HRmax, and the high-intensity exercise is assigned to exercise 4 days a week at 80–85% HRmax. The duration of the intervention is 18 months. Months 19 to 24 are observational